Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Olink Holding AB (publ) (OLK) Stock Forecast & Price Target

Olink Holding AB (publ) logo
Get the Latest News and Ratings for OLK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Olink Holding AB (publ) and its competitors.

Sign Up

OLK Analyst Ratings Over Time

TypeCurrent Forecast
11/18/23 to 11/17/24
1 Month Ago
10/19/23 to 10/18/24
3 Months Ago
8/20/23 to 8/19/24
1 Year Ago
11/18/22 to 11/18/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$26.00$26.00$26.00$24.75
Forecasted Upside-0.31% Downside-0.31% Downside-0.31% Downside-4.26% Downside
Consensus Rating
Hold
Hold
Hold
Hold

OLK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OLK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Olink Holding AB (publ) Stock vs. The Competition

TypeOlink Holding AB (publ)Medical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-0.31% Downside28,591.96% Upside9.87% Upside
News Sentiment Rating
Neutral News

See Recent OLK News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/26/2024Morgan Stanley
3 of 5 stars
 Reiterated RatingEqual Weight ➝ Equal Weight$26.00+7.13%
3/26/2024Canaccord Genuity Group
1 of 5 stars
 Reiterated RatingHold ➝ Hold$26.00+6.43%
10/18/2023Scotiabank
5 of 5 stars
 Reiterated RatingSector Outperform ➝ Sector Perform
10/17/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Souda
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
2/22/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$16.00 ➝ $18.00-20.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:27 AM ET.


OLK Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Olink Holding AB (publ) is $26.00, with a high forecast of $26.00 and a low forecast of $26.00.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Olink Holding AB (publ) in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OLK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OLK, but not buy additional shares or sell existing shares.

According to analysts, Olink Holding AB (publ)'s stock has a predicted downside of -0.31% based on their 12-month stock forecasts.

Analysts like Olink Holding AB (publ) less than other "medical" companies. The consensus rating for Olink Holding AB (publ) is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OLK compares to other companies.


This page (NASDAQ:OLK) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners